Cite
de la Torre A, Pérez K, Vega AM, et al. Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients. Breast Cancer (Auckl). 2016;10:5-11doi: 10.4137/BCBCR.S32785.
de la Torre, A., Pérez, K., Vega, A. M., Santiesteban, E., Ruiz, R., Hernández, L., Durrutí, D., Viada, C. E., Sánchez, L., Álvarez, M., Durán, Y., Moreno, Y. G., Arencibia, M., Cepeda, M., Domecq, M., Cabrera, L., Sánchez, J. L., Hernández, J. J., Valls, A. R., & Fernández, L. E. (2016). Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients. Breast cancer : basic and clinical research, 105-11. https://doi.org/10.4137/BCBCR.S32785
de la Torre, Ana, et al. "Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients." Breast cancer : basic and clinical research vol. 10 (2016): 5-11. doi: https://doi.org/10.4137/BCBCR.S32785
de la Torre A, Pérez K, Vega AM, Santiesteban E, Ruiz R, Hernández L, Durrutí D, Viada CE, Sánchez L, Álvarez M, Durán Y, Moreno YG, Arencibia M, Cepeda M, Domecq M, Cabrera L, Sánchez JL, Hernández JJ, Valls AR, Fernández LE. Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients. Breast Cancer (Auckl). 2016 Feb 18;10:5-11. doi: 10.4137/BCBCR.S32785. eCollection 2016. PMID: 26917965; PMCID: PMC4760670.
Copy
Download .nbib